%0 Journal Article %A Domagoj Kifer %A Dario Bugada %A Judit Villar-Garcia %A Ivan Gudelj %A Cristina Menni %A Carole Sudre %A Frano Vučković %A Ivo Ugrina %A Luca F Lorini %A Margarita Posso %A Silvia Bettinelli %A Nicola Ughi %A Alessandro Maloberti %A Oscar Epis %A Cristina Giannattasio %A Claudio Rossetti %A Livije Kalogjera %A Jasminka Peršec %A Luke Ollivere %A Benjamin J Ollivere %A Huadong Yan %A Ting Cai %A Guruprasad P. Aithal %A Claire J Steves %A Anu Kantele %A Mikael Kajova %A Olli Vapalahti %A Antti Sajantila %A Rafal Wojtowicz %A Waldemar Wierzba %A Zbigniew Krol %A Artur Zaczynski %A Katarina Zycinska %A Marek Postula %A Ivica Lukšić %A Rok Čivljak %A Alemka Markotić %A Johannes Brachmann %A Andreas Markl %A Christian Mahnkopf %A Benjamin Murray %A Sebastien Ourselin %A Ana M. Valdes %A Juan P Horcajada %A Xavier Castells %A Julio Pascual %A Massimo Allegri %A Dragan Primorac %A Tim D. Spector %A Clara Barrios %A Gordan Lauc %T Effects of environmental factors on severity and mortality of COVID-19 %D 2020 %R 10.1101/2020.07.11.20147157 %J medRxiv %P 2020.07.11.20147157 %X Background Most respiratory viruses show pronounced seasonality, but for SARS-CoV-2 this still needs to be documented.Methods We examined the disease progression of COVID-19 in 6,914 patients admitted to hospitals in Europe and China. In addition, we evaluated progress of disease symptoms in 37,187 individuals reporting symptoms into the COVID Symptom Study application.Findings Meta-analysis of the mortality risk in seven European hospitals estimated odds ratios per one day increase in the admission date to be 0.981 (0.973-0.988, p<0.001) and per increase in ambient temperature of one degree Celsius to be 0.854 (0.773-0.944, p=0.007). Statistically significant decreases of comparable magnitude in median hospital stay, probability of transfer to Intensive Care Unit and need for mechanical ventilation were also observed in most, but not all hospitals. The analysis of individually reported symptoms of 37,187 individuals in the UK also showed the decrease in symptom duration and disease severity with time.Interpretation Severity of COVID-19 in Europe decreased significantly between March and May and the seasonality of COVID-19 is the most likely explanation.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported in part by the European Structural and Investment Funds grant for the National Centre of Competence in Molecular Diagnostics (#KK.01.2.2.03.0006), National Centre of Research Excellence in Personalized Healthcare grant (#KK.01.1.1.01.0010) and IP CORONA-2020-04 grant from the Croatian Science Foundation. The Symptom Study app: Zoe provided in kind support for all aspects of building, running and supporting the app and service to all users worldwide. The Dept of Twin Research receives support from grants from the Wellcome Trust (212904/Z/18/Z) and the Medical Research Council (MRC)/British Heart Foundation Ancestry and Biological Informative Markers for Stratification of Hypertension (AIMHY; MR/M016560/1)., European Union, Chronic Disease Research Foundation (CDRF), Zoe Global Ltd, NIH and the National Institute for Health Research (NIHR)-funded BioResource, Clinical Research Facility and Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust in partnership with King's College London. CM is funded by the Chronic Disease Research Foundation and by the MRC Aim-Hy project grant. Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study protocol conformed to the ethical guidelines of the 1975 Declaration of Helsinki. In Zhejiang hospitals, ASST Papa Giovanni XXIII Hospital in Bergamo, Hospital del Mar in Barcelona and Helsinki University Hospital local ethics committees approved this retrospective study of COVID-19 patient data. For REGIOMED Hospital in Coburg, Ethics committee of the Bavarian state physician's association approved the study. In Nottingham University Hospital's trust, ASST GOM Niguarda, Warsaw and Zagreb this information was released as public statistical information.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data is available upon a reasonable reequest. %U https://www.medrxiv.org/content/medrxiv/early/2020/12/14/2020.07.11.20147157.full.pdf